Susceptibility of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae According to the New CLSI Breakpoints
Peng Wang(Singapore University of Technology and Design), Minggui Wang(Fudan University), Yun F. Wang(Emory University), Demei Zhu(Fudan University), Zizhong Xiong(Anhui Medical University), Xinyu Ye(Shenyang University of Technology), Fupin Hu(Huashan Hospital)
Cited by 60
Related Papers
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014
|Clinical Microbiology and Infection|2016|376
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Emerging Plasmid-Mediated Quinolone Resistance Associated with the <i>qnr</i> Gene in <i>Klebsiella pneumoniae</i> Clinical Isolates in the United States
|Antimicrobial Agents and Chemotherapy|2004|239